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Objective:   To identify factors that influence peri-operative hemorrhage in view of 
reducing the need for transfusions in patients undergoing trans uretheral resection of 
prostate (TURP). 
Methods: All patients undergoing TURP between January 1997 and December 1999 
were identified using lCD 9CM coding and indexing system. Overall 430 patients were 
identified, however, 384 charts were included and reviewed for demographics, pre and 
intra-operative data and post-operative morbidity. Patients were divided into two groups 
on the basis of presence of significant hemorrhage. 
Results:  Overall 384 patients were analyzed. Nineteen patients had hemorrhage - group I 
whereas 365had no significant hemorrhage - group II. Mean age and co-morbidities in the 
two groups were similar. However, in group I, 58% presented with urinary retention 
compared to 33% in group II. In group I, factors that reached statistical significance 
include; operative time (p<0.05), mean resected tissue weight (p<0.02), and patient 
presentation (urinary retention) (p<0.032). There was no significant difference in the two 
groups with respect to type of anesthesia (regional versus general) and histology of the 
resected tissue. Patients with mean pre-operative hemoglobin of 10.6 % had a 37% 
transfusion rate. 
Conclusion: Operative time, weight of resected prostate tissue are inter related and are 
only partly controllable. Low pre-operative hemoglobin is the only reversible factor in 
reducing transfusion following TURP (JPMA 53:1 04;2003). 
Introduction  
For the past 70 years, TURP has remained the gold standard in the management of 
bladder outlet obstruction due to prostatic enlargement. Advances in anesthesia, surgical 
technique video endoscopy and peri operative monitoring of fluid aiid electrolytes have 
considerably decreased the morbidity of the procedure.1 Peri-operative 
hemorrhage.infection and absorption of irrigation fluid are still important causes of 
morbidity. Pen-operative blood loss is a major complication and cause of great concern 
for both the surgeon and the patient. Many factors have been identified for their possible 
association with pen-operative bleeding. These include weight of the resected tissue, age 
of the patient, operating time, type of anesthesia, gland histology, presentation, 
symptomatology, presence of comorbidities, infections and use of medications.2 Urinary 
tract infection has also been reported in various recent reports, however, this was not 
considered in this paper due to lack of sufficient data. 
The present study is an audit of patients undergoing TURP during the last three years, 
conducted to study various factors influencing peri-operative hemorrhage and to identify 
ways of reducing need for transfusion. Better understanding of these factors and 
modifications, could effectively reduce this complication and need for transfusion. 
Patients and Methods  
Four hundred and thirty patients had TURP at our institution for symptomatic BPH or 
prostate cancer between January 1997 and December 1999. Complete medical records of 
384 (89.3%) patients were available, who were included in the study. In-patient and clinic 
records, laboratory and radiological workup, operative reports and discharge summaries 
were analyzed. The following parameters were documented for each patient; age, mode 
of presentation, co-morbidities (lschemic heart disease, hypertension. diabetes mellitus, 
chronic obstructive lung disease etc.) pre- and post- operative hemoglobin level, blood 
transfusion data, resected prostatic tissue weight, pathological diagnosis, resection time, 
intra-operative and post-operative complications and duration of hospital stay. The 
hospital stay was to ascertain the impact of procedure (TUR.P) related complications. 
The criteria used for identifying patients with unacceptable hemorrhage were 1) 
Excessive intra-operative or post-operative blood loss necessitating volume replacement / 
blood transfusion; and ii) Development of clot retention and need for readmission. 
Patients were divided into two groups; hemorrhage group (I) and no-hemorrhage group 
(II). Independent samples t-test was applied to test the difference in the two groups for 
age, preoperative hemoglobin level, operative time, weight of resected tissue and hospital 
stay. Similarly chi-square test with odds ratio was used to test the association of comi 
orbid ity. presentation, transfusion rate, and anesthesia between the two groups. The 
criteria used at our institution for blood transfusion include acute drop of hemoglobin >2 
gms% and a lesser drop of hemoglobin in patients with ischemic heart disease, chronic 
obstructive airway disease and other conditions affecting tissue perfusion. 
Results  
Out of 384 patients studied, 19 (4.95°/o) had significant post TURP bleeding, group I, 
whereas there was no significant bleeding in 365 (95.05%) patients. Mean age of the 
patients studied was 65 ±11 .2 years (range 45-95). There was no significant difference 
between the two groups with respect to age, co-morbid ities and mode of anesthesia 
(Tables 1 and 2). 
 
  
In group I. factors that reached statistical significance include; operative time (p<0.032). 
Patients requiring transfusion, group 1, had a low mean pre-operative hemoglobin level 
(10.6 gm% as compared to those who did not require blood transfusion, group II (13 
gm%) reaching statistical significance (p = 0.000). 
Seven patients (37%) in group I received transfusions. Indications for transfusion 
included acute drop in hemoglobin of more than 2 grarns% in 4, while three patients had 
a lesser drop in hemoglobin (mean 1.6 grams%) but due to presence of co-morbidities 
affecting tissue oxygen delivery, like ischemic heart disease and chronic obstructive 
pulmonary disease, a minimum hemoglobin concentration of 10 grams% was maintained 
by transfusions. 
Discussion  
Significant peri-operative hemorrhage, requiring blood transfusion is a major 
complication of TURP. 
Avoiding transfusion reduces the overall morbidity and the attendant risks of 
transmissible diseases. In the present study an attempt is made to identify various factors 
influencing pen-operative hemorrhage to avert need for transfusion. 
Blood transfusion requirements have greatly decreased in the last twenty years. In a study 
representative of 1 980’s practice. Mebust et at reported transfusion rate of 2.5% in over 
3000 patients undergoing TURP.’ Horninger et al.3 reported the need for transfusion in 
4.2%. Recently. Borboroglu et al.4 reviewed 520 consecutive patients undergoing 
transurethral prostatectomy at a single institution for symptomatic BPH between 1991 
and 1998. The transfusion requirement in this group of patients was only 0.4%. 
Identification of different factors influencing pen-operative hemorrhage has been 
addressed in various recent reports. Patients related factors like age, presentation, use of 
medications and procedure related factors like duration of surgery. type of anesthesia, 
histology of the gland, weight of resected tissue, have been described in literature. 
lbrahim et aL.5 noted that age of the patient does not influence hemorrhage in the TURP 
patients whereas presentation (lower urinary tract symptoms versus urinary retention) 
did. In our study about half the patients in group I presented with urinary retention 
compared to only 1/3 in the group II. 
The mean pre-operative hemoglobin in the hemorrhage group was 10.6~l.6 gm/dl 
compared to 12.9~1.8 gm/dl in the no hemorrhage group (p <0.000). Low mean pre-
operative hemoglobin level should not be regarded as a cause of bleeding but a need for 
earlier transfusion in case of hemorrhage. We feel that all patients, in particular with 
COPD and ischemic heart disease, undergoing elective TURP with a pre-operative 
hemoglobin under 11 gm% should be optimized before surgery. The overall transfusion 
rate in our study was 6.3%, which is somewhat higher than that reported from other multi 
center studies.1.4 Analysis of the pre and post-operative hemoglobin concentration 
confirmed that all transfusions of greater than 2 units were justified to avoid significant 
postoperative anemia (defined as a hemoglobin concentration of less than 10 gm/dl). The 
other factor, which was responsible for “the transfusion trigger” was the associated 
morbidity. Eight patients had ischemic heart disease or chronic obstructive pulmonary 
disease requiring approximately I Ogm% hemoglobin concentration to maintain adequate 
tissue perfusion. 
Operative time and weight of resected tissue were found to be different in the two groups. 
The mean operative time for the group I in our study was 107.8±51.6 minutes compared 
with 90.4±38.9 minutes for group II (p<0.O9). 
Similarly the mean resected tissue was 38.3+26 gm for group I and 21.4±14.3 gm for 
group El (p <0.02). Other investigators have also confirmed the association between 
resecred weight and blood loss.5.6 
Observation by other investigators7,8, that regional anesthesia is associated with less 
blood loss than general anesthesia was not confirmed in the present study. In the 
hemorrhage group 68.4 % had general anesthesia compared to 51.5% in the no 
hemorrhage group whereas 31.6% had regional anesthesia compared to 48.5% in the no 
hemorrhage group. This, however, did not reach statistical significance (P 0.15). Madsen 
and Madsen8 showed a statistically significant advantage in blood loss of spinal over 
general anesthesia (P<0.001) in a study of 180 patients. They suggested that the 
difference was probably the result of a reduction in blood pressure. However, other 
investigators have found no significant statistical difference between the type of 
anesthesia in relation to pen-operative blood loss.8 Like other investigators, ourstudy also 
shows that histology of the gland does not influence hemorrhage. Ibrahim et al.5 noted 
that avoiding infection and use of finasteride9 significantly reduces hemorrhage related to 
TURP. 
The present study clearly demonstrates that factors that ‘may influence the need for pen-
operative transfusions and reach statistical significance includes: pre-operative 
hemoglobin level, operative time, and weight of resected tissue. It does not show 
statistical significance of presentation, co-morbidities, type of anesthesia, and histology 
of the resected tissue in pen-operative hemorrhage and need for transfusion. Although 
low preoperative hemoglobin does not influence blood loss but increases the transfusion 
rate. pre-operative correction of anemia would decrease the need for transfusion and the 
risks associated with it. 
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